DR. TRACY M. BRENNER M.D. NPI 1053598896

NPI Information

  • NPI: 1053598896
  • Provider Name: DR. TRACY M. BRENNER, M.D.
  • Classification: Internal Medicine - 207RR0500X
  • Specialization: Rheumatology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 3124 SANTA MARGARITA RD
    WEST PALM BEACH, FL
    ZIP 33411
  • Phone: (614) 391-8005

Map and Directions

Get Directions

NPI Details

DR. Tracy M. Brenner, M.D. is a rheumatology internal medicine in West Palm Beach, FL. The provider is an internist who treats diseases of joints, muscle, bones and tendons. This specialist diagnoses and treats arthritis, back pain, muscle strains, common athletic injuries and collagen diseases. DR. Tracy M. Brenner, M.D. NPI is 1053598896. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

The provider's business location address is:

3124 SANTA MARGARITA RD
WEST PALM BEACH, FL
ZIP 33411-450
Phone: (614) 391-8005
Fax: (561) 659-3331

The NPI 1053598896 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, golimumab, 1 mg, for intravenous use (HCPCS:J1602)
  • Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS:J0129)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Injection, infliximab, excludes biosimilar, 10 mg (HCPCS:J1745)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Measurement c-reactive protein for detection of infection or inflammation (HCPCS:86140)
  • Red blood cell sedimentation rate, to detect inflammation, automated (HCPCS:85652)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Blood creatinine level (HCPCS:82565)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Liver enzyme (sgpt), level (HCPCS:84460)
  • Liver enzyme (sgot), level (HCPCS:84450)
  • Albumin (protein) level (HCPCS:82040)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test (HCPCS:85027)
  • Injection, triamcinolone acetonide, not otherwise specified, 10 mg (HCPCS:J3301)
  • Measurement of complement (immune system proteins), antigen, (HCPCS:86160)
  • Vitamin d-3 level (HCPCS:82306)
  • Complete ultrasound scan of joint (HCPCS:76881)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Tuberculosis test, gamma interferon (HCPCS:86480)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Manual urinalysis test with examination using microscope, automated (HCPCS:81001)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • Uric acid level, blood (HCPCS:84550)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • Analysis of substance using immunoassay technique, multiple step method (HCPCS:83516)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Aspiration and/or injection of fluid from large joint (HCPCS:20610)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg (HCPCS:J0702)
  • Screening test for autoimmune disorder (HCPCS:86038)
  • Rheumatoid factor level (HCPCS:86431)
  • Measurement of antibody for rheumatoid arthritis assessment (HCPCS:86200)
  • Creatine kinase (cardiac enzyme) level, total (HCPCS:82550)
  • Measurement of antibody for assessment of autoimmune disorder, titer (HCPCS:86039)
  • Measurement of dna antibody, native or double stranded (HCPCS:86225)
  • Measurement of dna antibody, single stranded (HCPCS:86226)
  • New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)

The enumeration date for this NPI number is 1/23/2008 and was last updated on 4/16/2025.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RR0500XInternal MedicineRheumatologyME166610FLORIDAYes

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.